Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-14
2008-12-23
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S387000, C514S388000
Reexamination Certificate
active
07468440
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
REFERENCES:
patent: 6011052 (2000-01-01), Padia et al.
patent: 6359061 (2002-03-01), Swayze et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2002/0151550 (2002-10-01), DeSimone et al.
patent: 2003/0060459 (2003-03-01), Carter et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0110736 (2004-06-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235836 (2004-11-01), Cherney
patent: 2005/0043392 (2005-02-01), Carter
patent: 3829594 (1990-03-01), None
patent: 2003-212157 (2002-07-01), None
patent: 2003277340 (2003-10-01), None
patent: WO 93/07867 (1993-04-01), None
patent: WO 97/08934 (1997-03-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 98/03473 (1998-01-01), None
patent: WO 98/06703 (1998-02-01), None
patent: WO 99/07351 (1999-02-01), None
patent: WO 99/07678 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 99/40913 (1999-08-01), None
patent: WO 99/40914 (1999-08-01), None
patent: WO 99/46991 (1999-09-01), None
patent: WO 00/17197 (2000-03-01), None
patent: WO 00/27800 (2000-05-01), None
patent: WO 00/46196 (2000-08-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 01/68593 (2001-09-01), None
patent: WO 01/74774 (2001-10-01), None
patent: WO 02/26697 (2002-04-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 02/060859 (2002-08-01), None
patent: WO 02/070523 (2002-09-01), None
patent: WO 03/037847 (2003-05-01), None
patent: WO 03/045378 (2003-06-01), None
patent: WO 03/068742 (2003-08-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004071460 (2004-08-01), None
patent: WO 2004098516 (2004-11-01), None
U.S. Appl. No. 10/776,828, filed Feb. 11, 2004.
U.S. Appl. No. 10/837,179, filed Apr. 29, 2004.
U.S. Appl. No. 10/776,586, filed Feb. 11, 2004.
Forbes, I.T. et al., “CCR2B Receptor Antagonists: Conversion of a Weak HTS Hit to a Potent Lead Compound”, Bioorganic & Medicinal Chemistry Letters, vol. 10, pp. 1803-1806 (2000).
Mirzadegan, T. et al., “Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists”, The Journal of Biological Chemistry, vol. 275, No. 33, pp. 25562-25571 (2000).
Baba, M. et al., “A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity”, Proc. Natl. Acad. Sci. USA, vol. 96, pp. 5698-5703 (1999).
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.
B. J. R. Nicolaus, “Symbiotic Approach to Drug Design”, Decision Making in Drug Research, pp. 173-186 (1983).
Bogie Terence J.
Bristol--Myers Squibb Company
Duncan Laurelee A.
Kumar Shailendra
LandOfFree
Malonamides and malonamide derivatives as modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Malonamides and malonamide derivatives as modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malonamides and malonamide derivatives as modulators of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4032913